Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma

Gynecologic Oncology

Volumn 73, Issue 3, 1999, Pages 430-432

  Harmon, Joseph P ^a   Purvin, Valerie A ^b   Guy, John ^c   Aptsiauri, Natalie ^c   Sutton, Gregory P ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b MIDWEST EYE INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CANCER ANTIBODY; CYCLOPHOSPHAMIDE; PACLITAXEL; WARFARIN;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM ENLARGEMENT; HUMAN; OVARY ADENOCARCINOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINOPATHY; VISUAL IMPAIRMENT;

EID: 0033018978     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5342     Document Type: Article

References (13)

1. Jacobson D M, Thirkill C E, Tipping S J. A clinical trial to diagnose paraneoplastic retinopathy. Ann Neurol. 28:1990;162-165.
2. Guy J R, Adamus G, Aptsiauri N, Flannery J, Hargrave P. Cancer-associated retinopathy: a new antibody. Ophthalmology. 100:1993;116-118.
3. Thirkill C E, Tait R C, Tyler N K, Roth A M, Keltner J L. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 33:1992;2768-2772.
4. Ing E B, Younge B R, Leavitt J A, Lee R A, Bostwick D G. Paraneoplastic retinopathy and gynecologic malignancy. J Pelvic Surg. 1:1995;79-83.
5. Peterson K, Rosenblum M K, Kotanides H, Posner J B. paraneoplastic cerebellar degeneration. Neurology. 42:1992;1931-1933.
6. Sawyer R A, Selhorst J B, Zimmerman L E, Hoyt W F. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 81:1976;606-608.
7. Crofts J W, Bachynski B N, Odel J G. Visual paraneoplastic syndrome with undifferentiated endometrial carcinoma. Can J Ophthalmol. 23:1988;128-129.
8. Keltner J L, Roth A M, Chang R S. Photoreceptor degeneration: possible autoimmune disorder. Arch Ophthalmol. 101:1983;564-567.
9. Klingele T G, Burde R M, Rappazzo J A, Isserman M I, Burgess D, Kantor O. Paraneoplastic retinopathy. J Clin Neuro-ophthalmol. 4:1984;239-245.
10. Rizzo J F, Gittinger J W. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology. 99:1992;1286-1291.
11. McGinnis J F, Lerious V, Pazik J, Elliott R W. Chromosomal assignment of the recoverin gene and cancer-associated retinopathy. Mammalian Genome. 4:1993;43-45.
12. Keltner J L, Thirkill C E, Tyler N K, Roth A M. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 110:1992;48-52.
13. Thirkill R E, Fitzgerald P, Sergott R C, Roth A M, Tyler N K, Keitner J L. Cancer associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells. N Engl J Med. 321:1989;1589-1590.